Financial Year |
March 31 2023 |
Monetary Funds |
6,539,396,757.00 |
Held-for-trading Financial Assets |
795,209,132.00 |
Notes Receivable |
112,527,852.00 |
Accounts Receivable |
2,112,295,498.00 |
Advances to Suppliers |
143,757,761.00 |
Other Receivables |
285,888,008.00 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
547,861,418.00 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
114,801,207.00 |
Total Current Assets |
11,465,902,284.00 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
8,926,809.00 |
Long-term Equity Investment |
2,711,489,284.00 |
Investment Properties |
-- |
Fixed Assetes |
2,344,886,816.00 |
Under-construction Projects |
155,722,335.00 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
2,703,621,304.00 |
R&D expenses |
428,782,728.00 |
Goodwill |
1,600,764,166.00 |
Long-Term Deferred and Prepaid Expenses |
27,927,634.00 |
Deferred Income Tax Assets |
59,672,218.00 |
Other Non-Current Assets |
70,981,306.00 |
Sub-Total of Non-Current Assets |
11,425,185,150.00 |
Total Assets |
22,891,087,434.00 |
Short-Term Loans |
3,355,000,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
765,985,370.00 |
Accounts Received In Advance |
22,390,371.00 |
Employee Compensation Payable |
614,894,171.00 |
Taxes Payable |
233,560,119.00 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
931,148,092.00 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
300,509,380.00 |
Other Current Liabilities |
213,464,516.00 |
Sub-Total of Current Liabilities |
8,747,904,041.00 |
Long-term Loans |
1,411,750,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
50,580,245.00 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
19,251,199.00 |
Other Non-Current Liabilities |
387,227,930.00 |
Sub-Total of Non-Current Liabilities |
2,056,653,471.00 |
Total Liabilities |
10,804,557,512.00 |
Paid-In Capital(Or Share Stock) |
3,433,405,036.00 |
Capital Surplus |
5,839,882,319.00 |
Surplus Reserve |
1,324,594,716.00 |
LESS:Treasury Stock |
1,193,126,026.00 |
Undistributed Profits |
1,647,463,685.00 |
Minority Stockholder's Interest |
1,032,433,200.00 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,054,096,722.00 |
Owner's Equity(Stockholder's Equity) |
12,086,529,922.00 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
22,891,087,434.00 |